Mark Sawicki - Mar 9, 2022 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role: Chief Scientific Officer
Signature: /s/ Mark Sawicki
Stock symbol: CYRX
Transactions as of: Mar 9, 2022
Transactions value $: -$43,781
Form type: 4
Date filed: 3/11/2022, 04:45 PM
Previous filing: Aug 13, 2021
Next filing: Mar 16, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYRX	Common Stock	Options Exercise	$0	+2.67K	+5.32%	$0.00	52.8K	Mar 9, 2022	Direct	F1
transaction	CYRX	Common Stock	Sale	-$43.8K	-1.41K	-2.67%	$31.05	51.4K	Mar 9, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYRX	Restricted Stock Rights	Options Exercise	$0	-2.67K	-25%	$0.00	8K	Mar 9, 2022	Common Stock	2.67K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
F2	Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
F3	The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.